BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17442844)

  • 1. Comparison of an ESAT-6/CFP-10 peptide-based enzyme-linked immunospot assay to a tuberculin skin test for screening of a population at moderate risk of contracting tuberculosis.
    Porsa E; Cheng L; Graviss EA
    Clin Vaccine Immunol; 2007 Jun; 14(6):714-9. PubMed ID: 17442844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a new ESAT-6/CFP-10 peptide-based gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population.
    Porsa E; Cheng L; Seale MM; Delclos GL; Ma X; Reich R; Musser JM; Graviss EA
    Clin Vaccine Immunol; 2006 Jan; 13(1):53-8. PubMed ID: 16426000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A T-cell-based enzyme-linked immunospot assay for tuberculosis screening in Chinese patients with rheumatic diseases receiving infliximab therapy.
    Xie X; Chen JW; Li F; Tian J; Gao JS; Zhang D
    Clin Exp Med; 2011 Sep; 11(3):155-61. PubMed ID: 21161670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.
    Vassilopoulos D; Stamoulis N; Hadziyannis E; Archimandritis AJ
    J Rheumatol; 2008 Jul; 35(7):1271-6. PubMed ID: 18381793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact.
    Arend SM; Engelhard AC; Groot G; de Boer K; Andersen P; Ottenhoff TH; van Dissel JT
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1089-96. PubMed ID: 11687445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can ELISpot replace the tuberculin skin test for latent tuberculosis?
    Greveson K
    Br J Nurs; 2009 Nov 12-25; 18(20):1248-54. PubMed ID: 20081663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of gamma interferon release assays using Mycobacterium tuberculosis antigens for diagnosis of latent and active tuberculosis in Mycobacterium bovis BCG-vaccinated populations.
    Zhang S; Shao L; Mo L; Chen J; Wang F; Meng C; Zhong M; Qiu L; Wu M; Weng X; Zhang W
    Clin Vaccine Immunol; 2010 Dec; 17(12):1985-90. PubMed ID: 20943878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an interferon-gamma release assay to diagnose latent tuberculosis infection in foreign-born patients.
    Brodie D; Lederer DJ; Gallardo JS; Trivedi SH; Burzynski JN; Schluger NW
    Chest; 2008 Apr; 133(4):869-74. PubMed ID: 18198254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area.
    Jiang W; Shao L; Zhang Y; Zhang S; Meng C; Xu Y; Huang L; Wang Y; Wang Y; Weng X; Zhang W
    BMC Immunol; 2009 May; 10():31. PubMed ID: 19476627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells.
    Chapman AL; Munkanta M; Wilkinson KA; Pathan AA; Ewer K; Ayles H; Reece WH; Mwinga A; Godfrey-Faussett P; Lalvani A
    AIDS; 2002 Nov; 16(17):2285-93. PubMed ID: 12441800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.
    Codecasa L; Mantegani P; Galli L; Lazzarin A; Scarpellini P; Fortis C
    J Clin Microbiol; 2006 Jun; 44(6):1944-50. PubMed ID: 16757583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?
    Soysal A; Toprak D; Koc M; Arikan H; Akoglu E; Bakir M
    Nephrol Dial Transplant; 2012 Apr; 27(4):1645-50. PubMed ID: 21931124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy.
    Sellam J; Hamdi H; Roy C; Baron G; Lemann M; Puéchal X; Breban M; Berenbaum F; Humbert M; Weldingh K; Salmon D; Ravaud P; Emilie D; Mariette X;
    Ann Rheum Dis; 2007 Dec; 66(12):1610-5. PubMed ID: 17456528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test.
    Lee SS; Chou KJ; Su IJ; Chen YS; Fang HC; Huang TS; Tsai HC; Wann SR; Lin HH; Liu YC
    Infection; 2009 Apr; 37(2):96-102. PubMed ID: 19139810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of an in-house and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infection.
    Mantegani P; Piana F; Codecasa L; Galli L; Scarpellini P; Lazzarin A; Cirillo D; Fortis C
    Clin Med Res; 2006 Dec; 4(4):266-72. PubMed ID: 17210976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
    Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
    Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection.
    Hill PC; Brookes RH; Fox A; Jackson-Sillah D; Jeffries DJ; Lugos MD; Donkor SA; Adetifa IM; de Jong BC; Aiken AM; Adegbola RA; McAdam KP
    PLoS Med; 2007 Jun; 4(6):e192. PubMed ID: 17564487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.